Navigation Links
Cardiva Medical, Inc. to Present at the UBS 2007 Global Life Science Conference With the Announcement of FDA 510(K) Clearance of its Newest Device: The Boomerang Catalyst II System(TM)
Date:9/20/2007

MOUNTAIN VIEW, Calif., Sept. 20 /PRNewswire/ -- Cardiva Medical, Inc., a privately held medical device company, announced today that Augustine Lien, Chairman and CEO, will present at the UBS 2007 Global Life Science Conference on Tuesday, September 25th in New York City. Notably, the company will be positioned to share information on its newest device, the Boomerang Catalyst II System, which recently received a 510(K) US market clearance. This new product builds on the success of its predecessor, the Boomerang Catalyst System TM, which launched in July 2007 with fast acceptance from cardiac centers across the U.S. given its unique product profile. Specifically, both the Boomerang Catalyst System and Boomerang Catalyst II System are the first vascular closure devices to achieve final hemostasis in the catheterization lab without leaving any foreign materials behind in the vessel, thereby eliminating a major cause of device failures, complications and re-access challenges.

Approved for both diagnostic and interventional procedures, Cardiva first introduced the original Boomerang Wire System in May 2005. While continuing to evolve its portfolio to meet the needs of its customers, Cardiva successfully enhanced the Boomerang Wire System in early 2007 by adding a proprietary hemostatic material to the spring-loaded section of the Boomerang Wire which accelerates coagulation adjacent to the puncture site. Cardiva launched this newly approved device in July as "Boomerang Catalyst System." The company has since enhanced the Boomerang Catalyst System to further improve the clinical performance of the Boomerang technology by adding an additional pro-coagulant to the proprietary hemostatic material of the Catalyst System. This new product will be released to the market under a trade name of "Boomerang Catalyst II System" in the fourth quarter of this year. To date, the portfolio of Boomerang devices has been used in more than 80,000 percutaneous catheterization pro
'/>"/>

SOURCE Cardiva Medical, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. Brain-child of Natus Medical, “Cool Cap”, Protects Brains of Babies Born With HE
2. Surgeons Presented Guidelines For Postoperative Atrial Fibrillation
3. Researchers Present Ways To Reduce The Risk Of Dementia
4. Researchers Present Data Regarding The Efficiency Of Herbs
5. Critically Ill Patients More At Risk Of Infection If Glucose Is Present In Their Lung Secretions
6. Ovarian Cancer Presents ‘Target Symptoms’ Six Months Before Diagnosi
7. Drug Reactions First Present Themselves In The Mouth
8. Reminiscing Into The Past Makes You Dissatisfied With The Present
9. Living In The Past Indicates Dissatisfaction With Present
10. Movies Represent Coma In A Wrong Way
11. Onchocerciasis: Presentation And Treatment
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2014)... CA (PRWEB) August 27, 2014 Ticket ... vs. Chile tickets at Levi’s Stadium in Santa Clara. ... in Santa Clara, California just opened in July and will ... when Mexico takes on Chile. These are two of the ... the 2014 World Cup and will look to continue their ...
(Date:8/27/2014)... Seattle, WA (PRWEB) August 27, 2014 ... services, call center solutions, and cloud-based business communication systems, ... Need to Know about HIPAA-compliant Secure Text Messaging .” ... what healthcare professionals need to do to remain compliant ... the author of the article and C.O.O. at Sound ...
(Date:8/27/2014)... August 27, 2014 Parker Waichman LLP, ... rights of victims injured by defective medical devices, reports ... for discovery procedures, specifically Collection and Preservation of Evidence, ... transvaginal mesh devices. (MDL No. 2187, In Re: C.R. ... United States District Court, Southern District or West Virginia; ...
(Date:8/27/2014)... 27, 2014 (HealthDay News) -- Pouring half a glass of wine ... to a new study. Researchers asked 74 college students and ... from bottles that had varying amounts of wine in them. The ... Those who had a "rule of thumb" about how much to ... two fingers from the top -- poured less wine than those ...
(Date:8/27/2014)... New York, New York (PRWEB) August 27, 2014 ... to be filed in U.S. courts on behalf of ... due to uterine morcellation, Bernstein Liebhard LLP reports. According ... was filed on August 18th in the U.S. District ... a hysterectomy patient who claims the use of a ...
Breaking Medicine News(10 mins):Health News:Mexico vs. Chile Tickets at Levi’s Stadium: Ticket Down Cuts Ticket Prices for Inaugural Soccer Match between Chile and Mexico in Santa Clara 2Health News:Mexico vs. Chile Tickets at Levi’s Stadium: Ticket Down Cuts Ticket Prices for Inaugural Soccer Match between Chile and Mexico in Santa Clara 3Health News:Sound Telecom Releases Article on Secure Messaging with Huge Implications for the Healthcare Industry 2Health News:Sound Telecom Releases Article on Secure Messaging with Huge Implications for the Healthcare Industry 3Health News:New Discovery Rules Have Been Put in Place by the Court Overseeing C.R. Bard Transvaginal Mesh Litigation, Parker Waichman LLP Comments 2Health News:New Discovery Rules Have Been Put in Place by the Court Overseeing C.R. Bard Transvaginal Mesh Litigation, Parker Waichman LLP Comments 3Health News:New Discovery Rules Have Been Put in Place by the Court Overseeing C.R. Bard Transvaginal Mesh Litigation, Parker Waichman LLP Comments 4Health News:'Half a Glass' Rule May Curb Overdrinking 2Health News:Power Morcellator Lawsuit Alleges Storz Morcellator Caused Spread of Aggressive Uterine Cancer, Bernstein Liebhard LLP Reports 2Health News:Power Morcellator Lawsuit Alleges Storz Morcellator Caused Spread of Aggressive Uterine Cancer, Bernstein Liebhard LLP Reports 3Health News:Power Morcellator Lawsuit Alleges Storz Morcellator Caused Spread of Aggressive Uterine Cancer, Bernstein Liebhard LLP Reports 4
... findings that suggest that programs to help the elderly see ... study. , The researchers led by Professor Robert ... Sydney’s Concord Hospital, examined more than 600 people aged over ... They found that these elders were 57 per ...
... has built an enviable reputation in the Malayalam movie industry, ... to his heart- AIDS. Mohanlal will be the goodwill ambassador ... a state where five HIV+ve children in Kottayam district were ... parents of other children, the contribution by the actor will ...
... who were affected with AIDS continue to grow into adolescents ... that HIV infected children will die before the age of ... stunted and they face problems when they enter the age ... HIV affected children at a clinic in Harare. They inferred ...
... on Tuesday, the World Health Organization along with twenty ... of fake drugs especially in developing countries. ... that sale of spurious drugs in some of the ... total drug sales. He said that this issue needs ...
... change in the procedure for HIV testing is reported to increase ... conducted// by Dr. Nicola M. Zetola from the University of California, ... testing rates before and after the withdrawal of a procedure which ... of HIV testing rose up from 13.5 HIV tests per 1000 ...
... function in a patient suffering from akinetic mutism. The patient ... after receiving the drug for a bout of insomnia. ... insomnia.,Akinetic mutism is a condition in which the person is ... study was published in the March 2007 issue of Annals ...
Cached Medicine News:Health News:Zolpidem Might Assist Patients With Akinetic Mutism 2
(Date:8/27/2014)... 2014 North American lighting leader OSRAM SYLVANIA ... for the new OSRAM ITOS ® PHASER ® ... for microscopy, endoscopy and surgical head lamps that delivers the ... and lamp life. "We,re honored to be recognized ... innovative new technologies of the past year," said Andreas ...
(Date:8/27/2014)... WOONSOCKET, R.I. , Aug. 27, 2014  CVS ... has entered into a new clinical affiliation with MedStar ... in Maryland and the ... access to high-quality, affordable health care services for patients. ... to have access to clinical support, medication counseling, chronic ...
(Date:8/27/2014)... NINGBO, China , Aug. 27, 2014 ... Pharmaceutical Co., Ltd, ("Menovo") today announced they had entered ... pharmaceuticals, primarily targeting the United States ... and Menovo will jointly develop products for Amerigen to ... Menovo will be responsible for manufacturing API and finished ...
Breaking Medicine Technology:OSRAM ITOS PHASER 3000 Laser and LED Light Module Recognized With Prestigious R&D 100 Award 2OSRAM ITOS PHASER 3000 Laser and LED Light Module Recognized With Prestigious R&D 100 Award 3CVS Caremark Announces New Clinical Affiliation with MedStar Health 2CVS Caremark Announces New Clinical Affiliation with MedStar Health 3Amerigen Pharmaceuticals Limited and the Ningbo Menovo Pharmaceutical Co., Ltd, today announced they had entered into a collaboration agreement regarding the development of generic pharmaceuticals, primarily targeting the United States market 2
Link All-Poly acetabular cups for cement....
Metal on metal hip acetabular cups available for both cemented and cementless applications, the Biomet Merck metal on metal articulation hip system (M2aTM) combines proven materials with the latest i...
Derived from an extensive study into increasing the range of motion in hip replacement, the cemented SHP acetabular cup is a unique design and is manufactured from ArCom polyethylene....
S-ROM acetabular cups provide a variety of geometrical options to help address many anatomical situations and defects....
Medicine Products: